Elizabeth Burt
Research Subjects
Elizabeth Burt has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
Ephia Yasmin
Reproductive Medicine Unit, Institute for Women's Health University College London Hospitals London UK
5 shared publicationsVikram Talaulikar
Reproductive Medicine Unit, Institute for Women's Health University College London Hospitals London UK
5 shared publicationsAntoinette Cameron‐Pimblett
Reproductive Medicine Unit, Institute for Women's Health University College London Hospitals London UK
3 shared publicationsGerard Conway
Reproductive Medicine Unit, Institute for Women's Health, University College London Hospitals London UK
3 shared publicationsMelanie C. Davies
Reproductive Medicine Unit, Institute for Women's Health University College London Hospitals London UK
3 shared publications- Rina Agrawal
University Hospitals Coventry and Warwickshire NHS Trust; Department of Obstetrics and Gynaecology; Coventry UK CV2 2DX
3 shared publications
Latest Publications
- Open Access
- 27 May 2024
- Published by Wiley in Clinical Endocrinology
- Vol. 101 (1) , 51-59
Fertility and pregnancy outcomes in women with Turner syndrome: A single centre experience
Objective: Many women with Turner syndrome (TS) will consider fertility options and pregnancy. We wished to examine the fertility and pregnancy outcomes in women with TS undergoing oocyte donation (OD) treatment or spontaneous pregnancy in a large single‐centre cohort. General population reference data or data from those with idiopathic premature ovarian insufficiency were used as comparators.Design: A retrospective single‐centre cross‐sectional study.Patients and Measurements: Seventy‐four women with TS underwent OD treatment with a total of 105 pregnancies, and 31 women with TS had 71 spontaneous conceptions. Fertility outcomes included clinical pregnancy and live birth rate. Pregnancy outcomes included miscarriage rate, prevalence of hypertension, gestational diabetes, lower segment caesarean section (LSCS), small for gestational age (SGA), prematurity and vertical transmission of TS.Results: In those with TS, OD pregnancies were associated with increased rates of LSCS and SGA compared to spontaneous pregnancies; LSCS (OR: 4.19, 95% CI: 1.6−10.8, p = .003) and SGA (OR: 2.92, 95% CI: 1.02−8.38, p = .04). There were no recorded cardiac events but 5 (17.2%) cases of vertical transmissions of TS in daughters were identified. OD in those with TS was associated with a lower live birth rate per cycle started (OR: 0.53, 95% CI: 0.34−0.84, p = .008) and a higher rate of miscarriage compared to women with POI (40% vs. 26.2%, p = .04).Conclusions: We show that pregnancy in women with TS, whether OD or spontaneously conceived, carries obstetric risks, and therefore, women with TS, considering pregnancy, should receive comprehensive pre‐pregnancy counselling and optimal obstetric care.
- 27 May 2024
- Published by Wiley in Clinical Endocrinology
- Vol. 101 (1) , 51-59
Open AccessFertility and pregnancy outcomes in women with Turner syndrome: A single centre experience
Objective: Many women with Turner syndrome (TS) will consider fertility options and pregnancy. We wished to examine the fertility and pregnancy outcomes in women with TS undergoing oocyte donation (OD) treatment or spontaneous pregnancy in a large single‐centre cohort. General population reference data or data from those with idiopathic premature ovarian insufficiency were used as comparators.Design: A retrospective single‐centre cross‐sectional study.Patients and Measurements: Seventy‐four women with TS underwent OD treatment with a total of 105 pregnancies, and 31 women with TS had 71 spontaneous conceptions. Fertility outcomes included clinical pregnancy and live birth rate. Pregnancy outcomes included miscarriage rate, prevalence of hypertension, gestational diabetes, lower segment caesarean section (LSCS), small for gestational age (SGA), prematurity and vertical transmission of TS.Results: In those with TS, OD pregnancies were associated with increased rates of LSCS and SGA compared to spontaneous pregnancies; LSCS (OR: 4.19, 95% CI: 1.6−10.8, p = .003) and SGA (OR: 2.92, 95% CI: 1.02−8.38, p = .04). There were no recorded cardiac events but 5 (17.2%) cases of vertical transmissions of TS in daughters were identified. OD in those with TS was associated with a lower live birth rate per cycle started (OR: 0.53, 95% CI: 0.34−0.84, p = .008) and a higher rate of miscarriage compared to women with POI (40% vs. 26.2%, p = .04).Conclusions: We show that pregnancy in women with TS, whether OD or spontaneously conceived, carries obstetric risks, and therefore, women with TS, considering pregnancy, should receive comprehensive pre‐pregnancy counselling and optimal obstetric care.
- 28 August 2022
- Published by Wiley in Clinical Endocrinology
- Vol. 98 (1) , 68-73
Challenges in developing a quantitative method of measuring breast development using 3D imaging: An example of a novel method for use in induced breast development with exogenous oestrogen
Objective: Optimal breast development is an essential part of exogenous oestrogen treatment in females undergoing pubertal induction. We set out to develop a novel technique using three‐dimensional (3D) imaging to determine change in breast volume that is applicable when no pre‐existing breast contours are present.Design: A prospective observational study.Patients: The imaging methodology was developed using a single male subject to assess reproducibility and validity. The technique was then applied to 29 participants undergoing pubertal induction with exogenous oestradiol who were recruited from Paediatric Gynaecology and Reproductive Endocrinology clinics at University College London Hospital.Measurements: Breast images were taken using a 3D photographic system. Two images, taken at different times, were manually superimposed to produce a differential breast volume. The initial step of method development set out to show that volume change was not secondary to positioning artefact or image manipulation. This was established by using images of a male participant taken on different occasions. The technique was then used to assess reproducibility in participants undergoing pubertal induction treatment.Results: Good intraobserver reproducibility (intraclass correlation (ICC) 0.77) was demonstrated with static image manipulation. Validity of the imaging technique was established as there was no significant difference between the known reference volume produced by computer generated warping and that calculated by manual image manipulation. There was excellent intraobserver reproducibility for breast volume calculation in participants undergoing induced breast development (ICC 0.99).Conclusions: 3D imaging is a promising novel tool to provide quantitative breast volume assessment in individuals undergoing breast induction with exogenous oestradiol treatment.
- 28 August 2022
- Published by Wiley in Clinical Endocrinology
- Vol. 98 (1) , 68-73
Challenges in developing a quantitative method of measuring breast development using 3D imaging: An example of a novel method for use in induced breast development with exogenous oestrogen
Objective: Optimal breast development is an essential part of exogenous oestrogen treatment in females undergoing pubertal induction. We set out to develop a novel technique using three‐dimensional (3D) imaging to determine change in breast volume that is applicable when no pre‐existing breast contours are present.Design: A prospective observational study.Patients: The imaging methodology was developed using a single male subject to assess reproducibility and validity. The technique was then applied to 29 participants undergoing pubertal induction with exogenous oestradiol who were recruited from Paediatric Gynaecology and Reproductive Endocrinology clinics at University College London Hospital.Measurements: Breast images were taken using a 3D photographic system. Two images, taken at different times, were manually superimposed to produce a differential breast volume. The initial step of method development set out to show that volume change was not secondary to positioning artefact or image manipulation. This was established by using images of a male participant taken on different occasions. The technique was then used to assess reproducibility in participants undergoing pubertal induction treatment.Results: Good intraobserver reproducibility (intraclass correlation (ICC) 0.77) was demonstrated with static image manipulation. Validity of the imaging technique was established as there was no significant difference between the known reference volume produced by computer generated warping and that calculated by manual image manipulation. There was excellent intraobserver reproducibility for breast volume calculation in participants undergoing induced breast development (ICC 0.99).Conclusions: 3D imaging is a promising novel tool to provide quantitative breast volume assessment in individuals undergoing breast induction with exogenous oestradiol treatment.
- 22 April 2022
- Published by Wiley in Clinical Endocrinology
- Vol. 97 (1) , 91-99
Variability of response to early puberty induction demonstrated by transverse uterine diameter measurement and a novel method of 3D breast imaging
Objective Induction of puberty with exogenous oestrogen results in considerable variability in final uterine and breast volumes. We set out to quantify the variability of these two outcome measures with a view to establishing monitoring methods that could be used to individualise treatment protocols. Design A prospective observational study. Participants Sixteen participants with pubertal delay and primary amenorrhoea, due to hypogonadism were recruited from paediatric gynaecology and endocrinology clinics at University College London Hospital. A standardised protocol of transdermal 17 beta oestradiol (17 beta E) was used (Evorel (TM)), with a starting dose of 12.5 mcg increasing to 25 mcg (patch changed twice weekly) after 4 months. Follow up was every 2 months for a total of 8 months. Measurements Uterine dimensions using ultrasound, oestradiol concentrations and breast development assessed by both Tanner staging and 3D photographic imaging. Results After 8 months of treatment, the changes in oestradiol concentrations (0-174 pmol), uterine volume growth (4.4-16.4 ml) and breast volume (1.76-140.1 ml) varied greatly between individuals. Of uterine parameters, transverse uterine diameter was most closely associated with serum oestradiol levels at 8 months (beta standardised coefficient = 0.80, p = .001). Change in breast volume was associated with age of treatment initiation (beta standardised coefficient 0.55 p = .04). Conclusions We demonstrate variation in response to exogenous oestrogen, emphasising the necessity for individualised dose titration. In the absence of sensitive oestradiol assays, uterine transverse measurements may be used as a surrogate marker of oestrogen sensitivity to guide early dose adjustment. 3D breast imaging may provide a quantitative assessment of breast development to complement Tanner breast staging.
- 22 April 2022
- Published by Wiley in Clinical Endocrinology
- Vol. 97 (1) , 91-99
Variability of response to early puberty induction demonstrated by transverse uterine diameter measurement and a novel method of 3D breast imaging
Objective Induction of puberty with exogenous oestrogen results in considerable variability in final uterine and breast volumes. We set out to quantify the variability of these two outcome measures with a view to establishing monitoring methods that could be used to individualise treatment protocols. Design A prospective observational study. Participants Sixteen participants with pubertal delay and primary amenorrhoea, due to hypogonadism were recruited from paediatric gynaecology and endocrinology clinics at University College London Hospital. A standardised protocol of transdermal 17 beta oestradiol (17 beta E) was used (Evorel (TM)), with a starting dose of 12.5 mcg increasing to 25 mcg (patch changed twice weekly) after 4 months. Follow up was every 2 months for a total of 8 months. Measurements Uterine dimensions using ultrasound, oestradiol concentrations and breast development assessed by both Tanner staging and 3D photographic imaging. Results After 8 months of treatment, the changes in oestradiol concentrations (0-174 pmol), uterine volume growth (4.4-16.4 ml) and breast volume (1.76-140.1 ml) varied greatly between individuals. Of uterine parameters, transverse uterine diameter was most closely associated with serum oestradiol levels at 8 months (beta standardised coefficient = 0.80, p = .001). Change in breast volume was associated with age of treatment initiation (beta standardised coefficient 0.55 p = .04). Conclusions We demonstrate variation in response to exogenous oestrogen, emphasising the necessity for individualised dose titration. In the absence of sensitive oestradiol assays, uterine transverse measurements may be used as a surrogate marker of oestrogen sensitivity to guide early dose adjustment. 3D breast imaging may provide a quantitative assessment of breast development to complement Tanner breast staging.
- 5 September 2019
- Published by Wiley in Clinical Endocrinology
- Vol. 91 (6) , 798-804
Reduced uterine volume after induction of puberty in women with hypogonadism
Objective: Adequate uterine growth is an essential component of pubertal induction with exogenous oestradiol in those with hypogonadism. Poor uterine development will render the individual vulnerable in the context of fertility. We assessed uterine size using ultrasound in those who had undergone pubertal induction treatment compared with a reference group who had experienced spontaneous puberty.Design: This is a single‐centre, retrospective, cross‐sectional study of women who underwent pubertal induction compared with a reference group.Patients: Ninety‐five women with hypogonadism who had previously undergone pubertal induction and were receiving maintenance oestrogen replacement as adults were recruited: 48 women with Turner syndrome, 32 with premature ovarian insufficiency and 15 with gonadotrophin deficiency. The reference group consisted of 35 nulliparous women attending with male factor subfertility with a normal pelvis on ultrasonography.Measurements: Pelvic ultrasound was performed by a single observer. Uterine dimensions (total length, anterior–posterior (AP), transverse, uterine volume and fundal cervical AP ratio (FCR) measurements) were recorded. Clinical details were also recorded.Results: Those with hypogonadism had significantly reduced uterine dimensions compared with the reference group (uterine length 64 mm vs 71 mm P = <.05, uterine volume 28.9 mL vs 43.9 mL P = <.05). All women in the reference group attained a mature uterine configuration with a FCR >1, compared with 84% of those with hypogonadism (P = .01). A total of 24% and 48% of the diagnostic group had total uterine length and uterine volume measurements less than the 5th percentile of the reference group, respectively. In a subgroup of 22 women in whom serum oestradiol concentrations could be analysed, there was a positive correlation between this parameter and uterine volume.Conclusion: Despite standard oestrogen therapy, uterine growth is often compromised in those with hypogonadism. Uterine health has historically been overlooked in pubertal induction protocols; however, with increasing options for fertility treatment, adequate uterine development is crucial. Given the variation in uterine size witnessed, a more tailored approach to treatment with regular monitoring of uterine dimensions should be advocated.
- 5 September 2019
- Published by Wiley in Clinical Endocrinology
- Vol. 91 (6) , 798-804
Reduced uterine volume after induction of puberty in women with hypogonadism
Objective: Adequate uterine growth is an essential component of pubertal induction with exogenous oestradiol in those with hypogonadism. Poor uterine development will render the individual vulnerable in the context of fertility. We assessed uterine size using ultrasound in those who had undergone pubertal induction treatment compared with a reference group who had experienced spontaneous puberty.Design: This is a single‐centre, retrospective, cross‐sectional study of women who underwent pubertal induction compared with a reference group.Patients: Ninety‐five women with hypogonadism who had previously undergone pubertal induction and were receiving maintenance oestrogen replacement as adults were recruited: 48 women with Turner syndrome, 32 with premature ovarian insufficiency and 15 with gonadotrophin deficiency. The reference group consisted of 35 nulliparous women attending with male factor subfertility with a normal pelvis on ultrasonography.Measurements: Pelvic ultrasound was performed by a single observer. Uterine dimensions (total length, anterior–posterior (AP), transverse, uterine volume and fundal cervical AP ratio (FCR) measurements) were recorded. Clinical details were also recorded.Results: Those with hypogonadism had significantly reduced uterine dimensions compared with the reference group (uterine length 64 mm vs 71 mm P = <.05, uterine volume 28.9 mL vs 43.9 mL P = <.05). All women in the reference group attained a mature uterine configuration with a FCR >1, compared with 84% of those with hypogonadism (P = .01). A total of 24% and 48% of the diagnostic group had total uterine length and uterine volume measurements less than the 5th percentile of the reference group, respectively. In a subgroup of 22 women in whom serum oestradiol concentrations could be analysed, there was a positive correlation between this parameter and uterine volume.Conclusion: Despite standard oestrogen therapy, uterine growth is often compromised in those with hypogonadism. Uterine health has historically been overlooked in pubertal induction protocols; however, with increasing options for fertility treatment, adequate uterine development is crucial. Given the variation in uterine size witnessed, a more tailored approach to treatment with regular monitoring of uterine dimensions should be advocated.
- 28 February 2019
- Published by Wiley in Clinical Endocrinology
- Vol. 90 (6) , 822-826
A critical assessment of case reports describing absent uterus in subjects with oestrogen deficiency
Summary: Objective: The dual diagnosis of hypoplastic uterus in association with ovarian dysgenesis is regularly reported but the pathogenesis of the association is unclear. The uterus, however, may be invisible to all imaging modalities without at least six months of exogenous oestrogen exposure in complete ovarian failure. We assessed all available case reports in this category to estimate whether the apparent association between primary ovarian insufficiency or Turner syndrome and Mullerian agenesis can be largely accounted for by oestrogen deficiency.Design: A literature review of all cases in which an association between ovarian insufficiency or Turner syndrome and hypoplastic uterus has been reported.Patients: PubMed was searched for all case reports associated with relevant key terms. In total, 22 publications with a total of 25 patients were identified and reviewed; 14 subjects had the normal female karyotype (46,XX), and 11 subjects had Turner Syndrome.Measurements: Proportion of subjects who had been exposed to adequate oestrogen prior to the absent uterine diagnosis.Results: A diagnosis of absent uterus was made prior to exposure to exogenous oestrogen in 22/25 (88%) of subjects with primary hypogonadism including 14/14 females with normal karyotype and 8/11 females with Turner syndrome.Conclusions: Oestrogen deficiency is a possible explanation for most subjects being reported as having Mullerian agenesis in association with Turner syndrome or primary ovarian insufficiency. In the presence of oestrogen deficiency, no conclusion can be made about the status of the uterus until adequate exposure to exogenous oestrogen has been completed and we suggest reassessment of the uterus when full adult dose has been reached towards the end of induction of puberty.
- 28 February 2019
- Published by Wiley in Clinical Endocrinology
- Vol. 90 (6) , 822-826
A critical assessment of case reports describing absent uterus in subjects with oestrogen deficiency
Summary: Objective: The dual diagnosis of hypoplastic uterus in association with ovarian dysgenesis is regularly reported but the pathogenesis of the association is unclear. The uterus, however, may be invisible to all imaging modalities without at least six months of exogenous oestrogen exposure in complete ovarian failure. We assessed all available case reports in this category to estimate whether the apparent association between primary ovarian insufficiency or Turner syndrome and Mullerian agenesis can be largely accounted for by oestrogen deficiency.Design: A literature review of all cases in which an association between ovarian insufficiency or Turner syndrome and hypoplastic uterus has been reported.Patients: PubMed was searched for all case reports associated with relevant key terms. In total, 22 publications with a total of 25 patients were identified and reviewed; 14 subjects had the normal female karyotype (46,XX), and 11 subjects had Turner Syndrome.Measurements: Proportion of subjects who had been exposed to adequate oestrogen prior to the absent uterine diagnosis.Results: A diagnosis of absent uterus was made prior to exposure to exogenous oestrogen in 22/25 (88%) of subjects with primary hypogonadism including 14/14 females with normal karyotype and 8/11 females with Turner syndrome.Conclusions: Oestrogen deficiency is a possible explanation for most subjects being reported as having Mullerian agenesis in association with Turner syndrome or primary ovarian insufficiency. In the presence of oestrogen deficiency, no conclusion can be made about the status of the uterus until adequate exposure to exogenous oestrogen has been completed and we suggest reassessment of the uterus when full adult dose has been reached towards the end of induction of puberty.
- 9 June 2018
- Published by Cambridge University Press (CUP)
In-Vitro Fertilization
The birth of Louise Joy Brown - the world's first baby born following in-vitro fertilization - heralded a medical revolution. Forty years later, many thousands of babies are born each year following IVF. Assisted reproduction is a global industry with a multi-billion dollar turnover. It is a complex mix of science, clinical management, bioethics, and commercial imperatives. Many of the pioneers of IVF are still with us and have a fascinating tale to tell. Here, they relate the story of the development of IVF and related technologies in a way that will prove invaluable to future generations of practitioners seeking to understand the genesis of the specialty. This is not an academic history: rather it takes an informal and anecdotal approach; informing and entertaining for generations of past, present and future medical and scientific specialists of IVF, alongside the millions of parents, who celebrated the successes of IVF treatment worldwide.
- 9 June 2018
- Published by Cambridge University Press (CUP)
In-Vitro Fertilization
The birth of Louise Joy Brown - the world's first baby born following in-vitro fertilization - heralded a medical revolution. Forty years later, many thousands of babies are born each year following IVF. Assisted reproduction is a global industry with a multi-billion dollar turnover. It is a complex mix of science, clinical management, bioethics, and commercial imperatives. Many of the pioneers of IVF are still with us and have a fascinating tale to tell. Here, they relate the story of the development of IVF and related technologies in a way that will prove invaluable to future generations of practitioners seeking to understand the genesis of the specialty. This is not an academic history: rather it takes an informal and anecdotal approach; informing and entertaining for generations of past, present and future medical and scientific specialists of IVF, alongside the millions of parents, who celebrated the successes of IVF treatment worldwide.
- 30 October 2017
- Published by Bioscientifica in Endocrine Abstracts
Uterine development: the effect of induction of puberty with oestrogen in primary Amenorrhoea
Introduction: The uterus develops during puberty and increases not only in length but also in width and depth, to achieve a mature shape. Pubertal induction with exogenous oestradiol aims to mimic this. Research to date shows variable results for the attainment of an adult uterine configuration in females with hypogonadism. Suboptimal uterine development is hypothesised to be a contributing factor for adverse reproductive outcomes in females with hypogonadism undergoing egg donation IVF. Methods: This is a single centre, retrospective, cross sectional study of females who underwent pubertal induction. Nulliparous females with a history of hypogonadism and pubertal induction, attending University College London Hospital, were recruited. A pelvic ultrasound was performed by a single observer and uterine dimensions and clinical data were recorded. The reference group consisted of 28 nulliparous women attending with male factor subfertility with a normal pelvis on ultrasonography. Results: Fifty-six females with hypogonadism were recruited; nine with Gonadotrophin Deficiency, 19 with Premature Ovarian Insufficiency and 28 with Turner Syndrome. The mean age of those with hypogonadism at the time of ultrasound scan was 25.5 years compared to 33.5 years for the reference group. Those with hypogonadism presented at an average age of 12.7 years and started oestradiol therapy at a mean age of 15.1 years. Females with hypogonadism achieved menarche significantly later than those with spontaneous puberty (16.6 years vs 13.2 years P=P=< 0.05, AP 24.3 mm vs 30.4 mm P=< 0.05, transverse 36.03 mm vs 41.6 mm P=< 0.05, volume 35.0 ml vs 48.9 ml P=< 0.05) Conclusion: Despite standard Oestradiol therapy, those with hypogonadism achieved significantly smaller uteri compared to the reference group. Not only was the uterine length suboptimal but also the AP and transverse measurements, suggesting an immature shape. Inadequate uterine development may contribute to negative fertility and pregnancy outcomes and therefore, understanding which factors influence uterine size in this cohort, will be paramount to optimise pubertal induction treatment.
- 30 October 2017
- Published by Bioscientifica in Endocrine Abstracts
Uterine development: the effect of induction of puberty with oestrogen in primary Amenorrhoea
Introduction: The uterus develops during puberty and increases not only in length but also in width and depth, to achieve a mature shape. Pubertal induction with exogenous oestradiol aims to mimic this. Research to date shows variable results for the attainment of an adult uterine configuration in females with hypogonadism. Suboptimal uterine development is hypothesised to be a contributing factor for adverse reproductive outcomes in females with hypogonadism undergoing egg donation IVF. Methods: This is a single centre, retrospective, cross sectional study of females who underwent pubertal induction. Nulliparous females with a history of hypogonadism and pubertal induction, attending University College London Hospital, were recruited. A pelvic ultrasound was performed by a single observer and uterine dimensions and clinical data were recorded. The reference group consisted of 28 nulliparous women attending with male factor subfertility with a normal pelvis on ultrasonography. Results: Fifty-six females with hypogonadism were recruited; nine with Gonadotrophin Deficiency, 19 with Premature Ovarian Insufficiency and 28 with Turner Syndrome. The mean age of those with hypogonadism at the time of ultrasound scan was 25.5 years compared to 33.5 years for the reference group. Those with hypogonadism presented at an average age of 12.7 years and started oestradiol therapy at a mean age of 15.1 years. Females with hypogonadism achieved menarche significantly later than those with spontaneous puberty (16.6 years vs 13.2 years P=P=< 0.05, AP 24.3 mm vs 30.4 mm P=< 0.05, transverse 36.03 mm vs 41.6 mm P=< 0.05, volume 35.0 ml vs 48.9 ml P=< 0.05) Conclusion: Despite standard Oestradiol therapy, those with hypogonadism achieved significantly smaller uteri compared to the reference group. Not only was the uterine length suboptimal but also the AP and transverse measurements, suggesting an immature shape. Inadequate uterine development may contribute to negative fertility and pregnancy outcomes and therefore, understanding which factors influence uterine size in this cohort, will be paramount to optimise pubertal induction treatment.
- 1 August 2016
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 33 (2) , 174-179
Variation in antral follicle counts at different times in the menstrual cycle: does it matter?
- 1 August 2016
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 33 (2) , 174-179
Variation in antral follicle counts at different times in the menstrual cycle: does it matter?
- 5 July 2015
- Published by Cambridge University Press (CUP)
- p. 208-215
Lifestyle, diet, and exercise in polycystic ovary syndrome
- 5 July 2015
- Published by Cambridge University Press (CUP)
- p. 208-215
Lifestyle, diet, and exercise in polycystic ovary syndrome